Company Filing History:
Years Active: 2020
Title: Anjurn Zafar: Innovator in Cancer Research
Introduction
Anjurn Zafar is a notable inventor based in Bruce, Australia. He has made significant contributions to the field of cancer research, particularly in the modulation of cancer stem cells. His innovative work aims to enhance the effectiveness of cancer treatments.
Latest Patents
Anjurn Zafar holds a patent titled "Stem Cell Modulation II." This patent discloses methods and compositions for modulating cancer stem cells. More specifically, it reveals the use of protein kinase C theta inhibitors (PKC-θ) for inhibiting the growth of PKC-θ-overexpressing cells, including cancer stem cells. The invention also focuses on enhancing the biological effects of chemotherapeutic drugs or irradiation on cancer cells, treating cancer, including metastatic cancer, and preventing cancer recurrence. He has 1 patent to his name.
Career Highlights
Anjurn Zafar is associated with Epiaxis Therapeutics Pty Ltd., where he continues to advance his research in cancer therapies. His work is pivotal in developing new strategies for combating cancer and improving patient outcomes.
Collaborations
Anjurn collaborates with Sudha Rao, a fellow researcher, to further explore innovative solutions in cancer treatment.
Conclusion
Anjurn Zafar's contributions to cancer research through his patent and work at Epiaxis Therapeutics Pty Ltd. highlight his commitment to improving cancer therapies. His innovative approaches may pave the way for more effective treatments in the future.